Viewing Study NCT01690468


Ignite Creation Date: 2025-12-24 @ 5:58 PM
Ignite Modification Date: 2026-02-25 @ 6:59 PM
Study NCT ID: NCT01690468
Status: TERMINATED
Last Update Posted: 2020-09-24
First Post: 2012-09-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: PTX-200 and Carboplatin in Ovarian Cancer
Sponsor: Prescient Therapeutics, Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module